Viral vectors encoding recombinant fviii variants with increased expression for gene therapy of hemophilia a

Abstract

The present disclosure provides, among other aspects, codon-altered polynucleotides encoding Factor VIII variants for expression in mammalian cells. In some embodiments, the disclosure also provides mammalian gene therapy vectors and methods for treating hemophilia A.

Dependencies are inferred from the claim text.